Evotec |

Evotec offers drug research, development and manufacturing services to pharmaceutical companies.

What section would you like to update?
  • Company Logo
  • Company Name & URL
  • Company Description
  • Founded Date
  • Company Status
  • HQ Address
  • Social Links
  • CEO Name & Picture
  • Competitor Set
  • Funding Events
  • Acquisition Events

If you'd like to make any changes to this portfolio we'd be happy to help. Please send info/sources to support@owler.com.


We'll be back up as soon as possible.

Visit owler.uservoice.com for FAQs

Evotec Revenue, Funding, Number of Employees, Competitors and Acquisitions

EVOTEC CEO

Werner Lanthaler

CEO

Werner Lanthaler

Approval Rating: 88/100

WEIGH-IN

How would you rate Werner Lanthaler as a CEO?

negative
You
neutral
You
positive
You

Founded:

1993

Headquarters:

HamburgHamburg

Status:

PublicOtherEVT

Industry Sector:

Health Care Services

Completeness:

- -

KEY STATS

Revenue

- -

What is Evotec's revenue?

<1M

Employees

- -

How many people work at Evotec?

Followers on Owler

- -

FOLLOW
UNFOLLOW

TOP COMPETITORS

Add a new competitor:

Thanks for your contribution!

Recalculating The Competitive Graph now...

ADD

Evotec was founded in 1993 and its headquarters is located in Hamburg, Hamburg, DE. Evotec has $93.5M in revenue and 670 employees. Evotec's top competitors are XOMA, Genmab and Bluebird Bio.

Evotec Competitive Set

COMPANYLEADERSHIPCEO SCORE

EMPLOYEES
(ESTIMATED IF PRIVATE)

TOTAL FUNDING

REVENUE
(ESTIMATED IF PRIVATE)

LIKELY OUTCOME
EvotecEvotec ceo

Werner Lanthaler

CEO

88/100
1XOMA ceoXOMA

James R Neal

CEO

86/10018
$47.9M
2Genmab ceoGenmab

Jan G. J. van de Winkel

President & CEO

96/100157$134M$185.1M
3Bluebird Bio ceoBluebird Bio

Nick Leschly

CEO

82/100328$236.5M$32.8M
4Sangamo BioSciences ceoSangamo BioSciences

Sandy Macrae

President & CEO

81/100131$52.5M$32.4M
5MorphoSys ceoMorphoSys

Simon Moroney

Co-Founder & CEO

79/100365$123.9M$49.7M
6uniQure ceouniQure

Matthew Kapusta

CEO

64/100251$163.1M$9M
7REGENXBIO ceoREGENXBIO

Ken Mills

President & CEO

96/100107$247M$10M
8Icagen ceoIcagen

Richard Cunningham

President & CEO

87/10074$58.8M$22.6M

Evotec Revenue History

company revenue img

Coming soon with Owler Pro!

If you'd like to learn more, please contact us at support@owler.com

$

Community Estimate

UPDATE THIS

Evotec Employee History

company revenue img

Coming soon with Owler Pro!

If you'd like to learn more, please contact us at support@owler.com

Community Estimate

UPDATE THIS

Evotec Leadership

NAMETITLESOCIAL MEDIA
Werner Lanthaler
Werner Lanthaler

CEO

CEO

Evotec Acquisitions

COMPANY ACQUIRED ACQUISITION DATEAMOUNTDESCRIPTION
Aptuit LLCAptuit LLCAug 2017300MAptuit provides drug discovery and pre-clinical testing services for pharmaceutical and biotechnology companies.
Cyprotex PLCCyprotex PLCOct 201667.5MCyprotex is a contract research organization specializing in pre-clinical ADME-Tox and DMPK for pharmaceutical, chemical and agrochemical markets
Euprotec Ltd.Euprotec Ltd.May 20145.3M
undefinedFeb 2011undisclosed

SEE MORE

SEE LESS

Evotec has acquired 4 companies.Evotec's latest acquisition was Aptuit LLC in Aug 2017. Aptuit provides drug discovery and pre-clinical testing services for pharmaceutical and biotechnology companies.

Evotec Funding History

Since Evotec was founded in 1993, it has participated in 3 rounds of funding. In total Evotec has raised $196.8M. Evotec's last funding round was on Sep 2017 for a total of $89.8M

ROUNDFUNDING DATE AMOUNTINVESTORS
DebtSep 2017$89.8MEuropean Investment Bank
EquitySep 2013$40M
IPONov 1999$67M

Total: $

Evotec Investments

COMPANYDESCRIPTIONSTATUSINVESTMENT DATE/SOURCEROUNDEXIT DATEFOLLOW
Exscientia develops an AI-based platform that researches and develops small molecule drugs.PrivateSep 27, 2017Equity
Forge offers a drug discovery platform for developing novel antibiotics to treat multi-drug resistant bacteria.PrivateApr 24, 2017Series A
Eternygen is a contract research organization that focuses on developing drugs for the rare diseases.PrivateJan 08, 2017Series A
Carrick Therapeutics is an oncology company that develops new therapies for the treatment of cancer.PrivateOct 02, 2016Series A
Topas is a biotechnology company that researches, develops and commercializes novel therapeutics for immune-mediated and autoimmune diseases.PrivateMar 21, 2016Series A

SEE MORE

SEE LESS

Evotec has acquired 4 companies.Evotec's latest acquisition was Aptuit LLC in Aug 2017. Aptuit provides drug discovery and pre-clinical testing services for pharmaceutical and biotechnology companies.

Evotec News

Evotec: Evotec, MaRS Innovation Declare First ProjectAfter the start of their 2017 partnership for inflammatory skin diseaseContract Pharma
Evotec: Designer Instrument Enclosures Available In Smaller SizesProduct AnnouncementOKW's EVOTEC designer desktop plastic enclosures are now available in a new smaller 150 size - increasing the range to three plan sizes. EVOTEC is designed for tough working environments. Applications...Contributed Author: OKW Enclosures, Inc. Topics: ElectronicsECN Magazine
Evotec: Evotec AG Release according to Article 41 of the WpHG the German Securities Trading Act with the objective of Europewide distributionEvotec AG Total Voting Rights Announcement31.01.2018 1429 Total Voting Rights Announcement transmitted by DGAP a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.Publication of total number of voting rights1....BioPortfolio
Evotec: Lab150 - a new paradigm in drug discoveryLab150 represents an opportunity for Canada to bridge the drug discovery gap with the objective of stimulating the formation of new ventures in Ontario,...Global University Venturing
Evotec: Evotec AG EVT Medical Equipment Deals and Alliances Profile Report Updated 21122017 Prices from USD $250SummaryEvotec AG Evotec is a drug discovery alliance and development partnership company. It identifies and develops small molecule drugs across various therapeutic areas such as cancer neurological and nephrological conditions cardiovascular inflammation ...BioPortfolio
Evotec: APEIRON, Evotec Receive First Milestone from SanofiUnder a 3-party alliance signed in August 2015Contract Pharma
Evotec: BRIEF-Apeiron and Evotec to split three million euros on achieving I-O milestonePrivately-held Austrian biotech Apeiron and Germany's Evotec are to split three million euros ($3.6...The Pharma Letter
Evotec: Evotec und Apeiron erhalten Meilensteinzahlung von SanofiVon Barbara Millner FRANKFURT Dow JonesIm Rahmen der Allianz von Evotec Apeiron Biologics und Sanofi fliet die erste Meilensteinzahlung. Der Betrag von 3 Millionen Euro den Sanofi zahlt ge...BioPortfolio
Evotec: EVOTEC : TO ATTEND UPCOMING INVESTOR CONFERENCES(4-traders.com) DGAP-News: Evotec AG / Key word(s): Conference EVOTEC TO ATTEND UPCOMING INVESTOR CONFERENCES 03.01.2018 / 11:42 The issuer is solely responsible for the content of this announcement. Hamburg, Germany, 03 January 2018: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) announced today that its management will be...http://www.4-traders.com/EVOTEC-AG-436047/news/EVOTEC-TO-ATTEND-UPCOMING-INVESTOR-CONFERENCES-25743354/?utm_medium=RSS&utm_content=201801034-traders
Evotec: Evotec Hier winken weitere KursgewinneLiebe Leser Evotec ist nun um einige Cent nach oben geklettert. Charttechnische Analysten sind unverndert der Meinung die Aktie befinde sich in einem klaren kurzfristigen Aufbruchsmodus und es ...BioPortfolio

SEE MORE

SEE LESS

Evotec Website History

Screengrabs of how the Evotec site has evloved. (Click to expand)

Evotec website history

Sep 2017

Evotec website history

Sep 2017

Evotec website history

May 2017

Evotec website history

Jan 2017

Evotec website history

Oct 2016

Evotec website history

Jul 2016

Evotec website history

Apr 2016

Evotec website history

Jan 2016

Evotec website history

Oct 2015

Evotec website history

Jul 2015

Evotec website history

Apr 2015

Evotec website history

Nov 2014

Evotec website history

Aug 2014

Evotec website history

May 2014

Owler has collected 14 screenshots of Evotec's website since May 2014. The latest Evotec website design screenshot was captured in Sep 2017.

Evotec Headquarters

undefined company logo

Essener Bogen 7 Manfred Eigen Campus

Hamburg, Hamburg 22419

49-40-5-60-81

Driving Directions

google map

Evotec Summary Information

Evotec offers drug research, development and manufacturing services to pharmaceutical companies. Evotec was founded in 1993. Evotec's headquarters is located in Hamburg, Hamburg, DE 22419. It has raised 196.8M in 3 rounds. The latest round was in Sep 2017. Some of Evotec's investors include European Investment Bank and . Evotec's CEO, Werner Lanthaler, currently has an approval rating of 88%. 75% of Owler community believes the stock will go Up. Evotec has 670 employees and reported 93.5M in revenue [trailing four quarters].

Evotec's CEO, Werner Lanthaler, currently has an approval rating of 88%. Evotec's primary competitors are  XOMA Genmab Bluebird Bio.

Visit the Evotec website to learn more.